Clinical Trial Update: Thyroid Hormone for Remyelination in Multiple Sclerosis (MS): A Safety and Dose Finding Study [Phase 1]

View source ↗

Summary

Phase 1 safety and dose-finding study of thyroid hormone for remyelination in multiple sclerosis completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Thyroid hormone

Snippet

Sponsor: Oregon Health and Science University | Conditions: Multiple Sclerosis | Phase 1 | Status: COMPLETED | Results posted: 2018-11-19